200 related articles for article (PubMed ID: 31039704)
1. [CME: Update Actinic Keratoses].
Angehrn S; Tschernitz S
Praxis (Bern 1994); 2019 Apr; 108(6):381-388. PubMed ID: 31039704
[TBL] [Abstract][Full Text] [Related]
2. [Not Available].
Velter C
Ann Dermatol Venereol; 2019 May; 146 Suppl 2():IIS3-IIS9. PubMed ID: 31133227
[TBL] [Abstract][Full Text] [Related]
3. Topical AC-11 abates actinic keratoses and early squamous cell cancers in hairless mice exposed to Ultraviolet A (UVA) radiation.
Mentor JM; Etemadi A; Patta AM; Scheinfeld N
Dermatol Online J; 2015 Apr; 21(4):. PubMed ID: 25933088
[TBL] [Abstract][Full Text] [Related]
4. [Actinic keratoses].
Babilas P; Landthaler M; Szeimies RM
Hautarzt; 2003 Jun; 54(6):551-60; quiz 561-2. PubMed ID: 12858853
[TBL] [Abstract][Full Text] [Related]
5. Actinic keratosis and squamous cell carcinoma: clinical and pathological features.
Filosa A; Filosa G
G Ital Dermatol Venereol; 2015 Aug; 150(4):379-84. PubMed ID: 26099352
[TBL] [Abstract][Full Text] [Related]
6. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer.
Erlendsson AM
Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115209
[TBL] [Abstract][Full Text] [Related]
7. Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects.
Reinehr CPH; Bakos RM
An Bras Dermatol; 2019; 94(6):637-657. PubMed ID: 31789244
[TBL] [Abstract][Full Text] [Related]
8. The clinical course of actinic keratosis correlates with underlying molecular mechanisms.
Bakshi A; Shafi R; Nelson J; Cantrell WC; Subhadarshani S; Andea A; Athar M; Elmets CA
Br J Dermatol; 2020 Apr; 182(4):995-1002. PubMed ID: 31299087
[TBL] [Abstract][Full Text] [Related]
9. Actinic keratosis among seafarers.
Oldenburg M; Kuechmeister B; Ohnemus U; Baur X; Moll I
Arch Dermatol Res; 2013 Nov; 305(9):787-96. PubMed ID: 23818098
[TBL] [Abstract][Full Text] [Related]
10. Actinic keratoses contiguous with squamous cell carcinomas are mostly non-hyperkeratotic and with severe dysplasia.
Heerfordt IM; Poulsen T; Wulf HC
J Clin Pathol; 2022 Aug; 75(8):560-563. PubMed ID: 33863749
[TBL] [Abstract][Full Text] [Related]
11. Actinic keratosis: facts and controversies.
Ko CJ
Clin Dermatol; 2010; 28(3):249-53. PubMed ID: 20541675
[TBL] [Abstract][Full Text] [Related]
12. Neoantigen Fitness Model Predicts Lower Immune Recognition of Cutaneous Squamous Cell Carcinomas Than Actinic Keratoses.
Borden ES; Kang P; Natri HM; Phung TN; Wilson MA; Buetow KH; Hastings KT
Front Immunol; 2019; 10():2799. PubMed ID: 31849976
[TBL] [Abstract][Full Text] [Related]
13. [Beyond actinic keratoses: Field cancerization of the skin].
Reygagne P; Rostain G
Ann Dermatol Venereol; 2018 Oct; 145(10):587-592. PubMed ID: 30243819
[TBL] [Abstract][Full Text] [Related]
14. Actinic keratosis. Current treatment options.
Jeffes EW; Tang EH
Am J Clin Dermatol; 2000; 1(3):167-79. PubMed ID: 11702298
[TBL] [Abstract][Full Text] [Related]
15. Pathology and pathobiology of actinic (solar) keratosis - an update.
Roewert-Huber J; Stockfleth E; Kerl H
Br J Dermatol; 2007 Dec; 157 Suppl 2():18-20. PubMed ID: 18067626
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Cribier B
Ann Dermatol Venereol; 2019 May; 146 Suppl 2():IIS10-IIS15. PubMed ID: 31133224
[TBL] [Abstract][Full Text] [Related]
17. Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issues.
Quatresooz P; Piérard-Franchimont C; Paquet P; Hubert P; Delvenne P; Piérard GE
Eur J Dermatol; 2008; 18(1):6-10. PubMed ID: 18086582
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin.
Hodges A; Smoller BR
Mod Pathol; 2002 Nov; 15(11):1121-5. PubMed ID: 12429789
[TBL] [Abstract][Full Text] [Related]
19. [S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen: S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care].
Heppt MV; Leiter U; Steeb T; Alter M; Amaral T; Bauer A; Bechara FG; Becker JC; Breitbart EW; Breuninger H; Diepgen T; Dirschka T; Eigentler T; El Gammal AKS; Felcht M; Flaig MJ; Follmann M; Fritz K; Grabbe S; Greinert R; Gutzmer R; Hauschild A; Hillen U; Ihrler S; John SM; Kofler L; Koelbl O; Krause-Bergmann A; Kraywinkel K; Krohn S; Langer T; Loquai C; Löser CR; Mohr P; Nashan D; Nothacker M; Pfannenberg C; Salavastru C; Schmitz L; Stockfleth E; Szeimies RM; Ulrich C; Voelter-Mahlknecht S; Vordermark D; Weichenthal M; Welzel J; Wermker K; Wiegand S; Garbe C; Berking C
J Dtsch Dermatol Ges; 2023 Oct; 21(10):1249-1262. PubMed ID: 37845050
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor gene numerical aberrations are frequent events in actinic keratoses and invasive cutaneous squamous cell carcinomas.
Toll A; Salgado R; Yébenes M; Martín-Ezquerra G; Gilaberte M; Baró T; Solé F; Alameda F; Espinet B; Pujol RM
Exp Dermatol; 2010 Feb; 19(2):151-3. PubMed ID: 20156290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
